Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

IART Integra LifeSciences Holdings Corporation

22,25

0,00 (0,00%)

09 Jan 2025 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

12/03/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Eric Ian Schwartz

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Integra LifeSciences (NASDAQ:IART)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025

Plus de graphiques de la Bourse Integra LifeSciences

Integra LifeSciences (NASDAQ:IART)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025

Plus de graphiques de la Bourse Integra LifeSciences

Actualités Integra LifeSciences Holdings Corporation

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 8 Janvier 2025 ( il y a 22 heures) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Mardi 7 Janvier 2025 ( il y a 2 jours) • Edgar (US Regulatory)

Form 8-K - Current report
Lundi 6 Janvier 2025 ( il y a 3 jours) • Edgar (US Regulatory)

Form 8-K - Current report
Mardi 17 Décembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 4 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mardi 3 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 3 Décembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Mardi 12 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mardi 12 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Lundi 4 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 4 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Lundi 4 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Plus d'articles sur Integra LifeSciences Holdings Corporation

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales